Atomoxetine Versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder: A Double-Blind, Randomized, Multicenter Trial in Germany

2011 ◽  
Vol 21 (2) ◽  
pp. 97-110 ◽  
Author(s):  
Ralf W. Dittmann ◽  
Alexander Schacht ◽  
Karin Helsberg ◽  
Christian Schneider-Fresenius ◽  
Martin Lehmann ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Children And Adolescents ◽  
Oppositional Defiant Disorder ◽  
Attention Deficit ◽  
Multicenter Trial ◽  
Double Blind ◽  
Hyperactivity Disorder ◽  
Oppositional Defiant

scholarly journals PREVALENCE OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, OPPOSITIONAL DEFIANT DISORDER AND CONDUCT DISORDER IN CHILDREN WITH AUTISM SPECTRUM DISORDER

2017 ◽  
Vol 5 (2) ◽  
pp. 39-46 ◽  
Author(s):  
Milena Pereira Pondé ◽  
Mirella Lins Matos ◽  
Cinthia Cristina Pinto Bispo de Oliveira
Keyword(s):  
Autism Spectrum Disorder ◽  
Attention Deficit Hyperactivity Disorder ◽  
Conduct Disorder ◽  
Children And Adolescents ◽  
Oppositional Defiant Disorder ◽  
Attention Deficit ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Hyperactivity Disorder ◽  
Oppositional Defiant

Aim:  To estimate the prevalence of attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder (ODD) and conduct disorder (CD) in children and adolescents previously diagnosed with autism spectrum disorder (ASD). Methods:  A cross-sectional study involving 71 children and adolescents previously diagnosed by a psychiatrist as having ASD.  All were enrolled at a school that accompanies only individuals with ASD.  The evaluation instruments consisted of a sociodemographic questionnaire and the Brazilian version of the semi-structured interview Kiddie-SADS-PL for the investigation of psychiatric disorders in children and adolescents.  Results:  Overall, 62% of the children in the sample had some psychiatric comorbidity: 49.3% had some form of ADHD, 11.3% ODD and 1.4% CD.   In relation to the children with ADHD, 11.3% fulfilled the criteria for the inattentive subtype, 12.7% for the hyperactive/impulsive subtype, 7.1% for the combined subtype and 18.3% for ADHD not otherwise specified.  Conclusion:  These results ratify the clinical heterogeneity of ASD and highlight the importance of diagnosing comorbidities that could affect the clinical status and functioning level of children and adolescents with ASD.

Sign in / Sign up

Export Citation Format

Share Document